Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Was On Hold Is New Again As Impact Raises $22.5m For Fedratinib

Executive Summary

Medicxi-funded Impact Biomedicines gave Sanofi a stake in the start-up to acquire fedratinib and bring the JAK2 inhibitor, which was placed on a clinical hold in 2013, to patients who are out of options.

Advertisement

Related Content

Keeping Track: Accelerated Approval For Tecentriq And A Burst Of Filings And Submissions
Start-Up Quarterly Statistics: Financings Finally Rise In Q1, But Deals Stagnate
US FDA Tweaks IND Clinical Hold Policy As Number Of Holds Rises
Celgene Focuses On Deals, Pipeline As Post-Revlimid Future Draws Closer
Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches
Google Joins Novartis Backing Medicxi’s New $300m Late-Stage Fund
Sanofi kills PhIII JAK2 inhibitor on safety grounds
Sanofi-Aventis to pay up to $560 million for single product TargeGen

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099670

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel